220 related articles for article (PubMed ID: 24260741)
21. Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray.
Chen W; Fu X; Sun X; Sun T; Zhao Z; Sheng Z
J Surg Res; 2003 Aug; 113(2):208-16. PubMed ID: 12957131
[TBL] [Abstract][Full Text] [Related]
22. Effects of botulinum toxin type A on expression of genes in keloid fibroblasts.
Xiaoxue W; Xi C; Zhibo X
Aesthet Surg J; 2014 Jan; 34(1):154-9. PubMed ID: 23709452
[TBL] [Abstract][Full Text] [Related]
23. Single-Cell RNA-Sequencing Reveals Lineage-Specific Regulatory Changes of Fibroblasts and Vascular Endothelial Cells in Keloids.
Liu X; Chen W; Zeng Q; Ma B; Li Z; Meng T; Chen J; Yu N; Zhou Z; Long X
J Invest Dermatol; 2022 Jan; 142(1):124-135.e11. PubMed ID: 34242659
[TBL] [Abstract][Full Text] [Related]
24. Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts.
Mikulec AA; Hanasono MM; Lum J; Kadleck JM; Kita M; Koch RJ
Arch Facial Plast Surg; 2001; 3(2):111-4. PubMed ID: 11368663
[TBL] [Abstract][Full Text] [Related]
25. Antifibrotic Effects of High-Mobility Group Box 1 Protein Inhibitor (Glycyrrhizin) on Keloid Fibroblasts and Keloid Spheroids through Reduction of Autophagy and Induction of Apoptosis.
Jeon YR; Roh H; Jung JH; Ahn HM; Lee JH; Yun CO; Lee WJ
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450620
[TBL] [Abstract][Full Text] [Related]
26. p53 and apoptosis alterations in keloids and keloid fibroblasts.
Ladin DA; Hou Z; Patel D; McPhail M; Olson JC; Saed GM; Fivenson DP
Wound Repair Regen; 1998; 6(1):28-37. PubMed ID: 9776848
[TBL] [Abstract][Full Text] [Related]
27. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs.
Li C; Bai Y; Liu H; Zuo X; Yao H; Xu Y; Cao M
Acta Biochim Biophys Sin (Shanghai); 2013 Aug; 45(8):692-9. PubMed ID: 23709205
[TBL] [Abstract][Full Text] [Related]
29. Gene expression patterns in isolated keloid fibroblasts.
Satish L; Lyons-Weiler J; Hebda PA; Wells A
Wound Repair Regen; 2006; 14(4):463-70. PubMed ID: 16939575
[TBL] [Abstract][Full Text] [Related]
30. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
31. miR-194-5p serves a suppressive role in human keloid fibroblasts via targeting NR2F2.
Xu Q; Jiang S
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33200800
[TBL] [Abstract][Full Text] [Related]
32. Annexin A2 participates in human skin keloid formation by inhibiting fibroblast proliferation.
Kim SH; Jung SH; Chung H; Jo DI; Kim CK; Park SH; Won KJ; Jeon HS; Kim B
Arch Dermatol Res; 2014 May; 306(4):347-57. PubMed ID: 24402284
[TBL] [Abstract][Full Text] [Related]
33. Increased periostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions.
Zhang Z; Nie F; Kang C; Chen B; Qin Z; Ma J; Ma Y; Zhao X
Int J Mol Med; 2014 Jul; 34(1):253-61. PubMed ID: 24788198
[TBL] [Abstract][Full Text] [Related]
34. [Pathological genomics of keloid fibroblastic cells].
Wang CM; Hyakusok H; Zhang QX; Yan L; Nakazawa N
Zhonghua Zheng Xing Wai Ke Za Zhi; 2005 Jul; 21(4):299-301. PubMed ID: 16248530
[TBL] [Abstract][Full Text] [Related]
35. RUNX3 expression is associated with sensitivity to pheophorbide a-based photodynamic therapy in keloids.
Zheng Z; Zhu L; Zhang X; Li L; Moon S; Roh MR; Jin Z
Lasers Med Sci; 2015 Jan; 30(1):67-75. PubMed ID: 24957188
[TBL] [Abstract][Full Text] [Related]
36. Nonmuscle Myosin II Activation Regulates Cell Proliferation, Cell Contraction, and Myofibroblast Differentiation in Keloid-Derived Fibroblasts.
Lu YY; Fang CC; Hong CH; Wu CH; Lin YH; Chang KL; Lee CH
Adv Wound Care (New Rochelle); 2020 Sep; 9(9):491-501. PubMed ID: 32941122
[No Abstract] [Full Text] [Related]
37. Proliferating activity of dermal fibroblasts in keloids and hypertrophic scars.
Nakaoka H; Miyauchi S; Miki Y
Acta Derm Venereol; 1995 Mar; 75(2):102-4. PubMed ID: 7604635
[TBL] [Abstract][Full Text] [Related]
38. Deep and superficial keloid fibroblasts contribute differentially to tissue phenotype in a novel in vivo model of keloid scar.
Supp DM; Hahn JM; Glaser K; McFarland KL; Boyce ST
Plast Reconstr Surg; 2012 Jun; 129(6):1259-1271. PubMed ID: 22634643
[TBL] [Abstract][Full Text] [Related]
39. Heat Shock Protein 90 Inhibitor (17-AAG) Induces Apoptosis and Decreases Cell Migration/Motility of Keloid Fibroblasts.
Yun IS; Lee MH; Rah DK; Lew DH; Park JC; Lee WJ
Plast Reconstr Surg; 2015 Jul; 136(1):44e-53e. PubMed ID: 26111331
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.
Dienus K; Bayat A; Gilmore BF; Seifert O
Arch Dermatol Res; 2010 Dec; 302(10):725-31. PubMed ID: 20872224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
